2025 marks 30 years of The American Journal of Managed Care®. To commemorate this milestone, we’re sharing even more valuable content, from exclusive interviews and insights from thought leaders to facts and figures on our 3 decades of impact.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
Updated Clinical Guidelines Outline Optimal Treatment of Helicobacter pylori Infection
Recently Arrived Migrants Less Likely to Receive HIV Treatment
Prostate Cancer Studies Show Why Personalized Treatment, Trial Diversity Matter, Dorff Says
Redefining Functional Measures in SMA: Insights From Clinical Research
Collaborative Approaches Provide Comprehensive Support in Cancer Care
5 Key Health Care Moments During President Trump's First Month Back in Office
The Need for Payer Support in Overcoming Cancer Care Disparities
NSCLC Advancements Offer Hope, but Disparities Persist
Geographic Barriers Impede Access to Novel Cancer Treatments
Fueling Cancer Research Breakthroughs With Patient Contributions
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
Clinical Insights, Strategies for Delivering Equitable Psoriatic Arthritis Care
Cancer Mortality Rates Still High Among Black Patients, Despite Overall Decline
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
Step Edits Associated with IV Iron Therapies
Latest ASH Updates: Clinical Use of BTK Inhibitors in Management of CLL and MCL
Advancing Hematologic Care and the Future of Shared Decision-Making
Knowing Risk Factors for AMD Can Lead to Best Prognosis
Collaborative Approaches Provide Comprehensive Support in Cancer Care
Health Care Quality Measures Remain Resilient Amid Localized Disasters
Barriers That Prevent Access to Optimal Treatment in Primary Urethral Cancer
The Need for Payer Support in Overcoming Cancer Care Disparities
Impact of Patient-Reported Outcomes and Real-World Evidence in CLL and MCL
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
Prostate Cancer Studies Show Why Personalized Treatment, Trial Diversity Matter, Dorff Says
Barriers That Prevent Access to Optimal Treatment in Primary Urethral Cancer
Getting More Doctors to Record a Life-Saving Prostate Cancer Calculation
Managed Care Reflections: Insights From Richard J. Gilfillan, MD; and Donald M. Berwick, MD, MPP
Clinical Trials Must Represent Those Who Will Receive Therapy
A New Horizon: Precision Medicine and Value-Based Care in Lung, Gastric, and Sarcoma Cancers
What Recent Evidence Is Telling Us About Alcohol and Cancer
KAP Regarding ChatGPT Among Health Care Professionals: Correspondence
Medical Policy Determinations for Pharmacogenetic Tests Among US Health Plans
MRD and Other Predictors From FELIX for Obe-Cel Success in R/R B-ALL
Effects of Individualized Nurse-Led Care Plans on Olaparib Treatment Duration
Physiologic Insulin Resensitization Lowers Cost in Patients With Diabetes and Kidney Disease
Telephone Follow-Up on Medicare Patient Surveys Remains Critical
Challenges in Treatment of Desmoid Tumors and Managed Care Solutions
Desmoid Tumors: What Managed Care Professionals Need to Know to Manage These Unpredictable Tumors, featuring a Pharmacy Focus Podcast
Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care
Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Managed Care
Novel Therapies and Emerging Strategies for HR+/HER2- Metastatic Breast Cancer and the Impact on Patient Outcomes
Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies
Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Know
Keeping Pace With New Developments in Multiple Myeloma: Updates and Strategies to Optimize Bispecific Antibodies and CAR T-Cell Therapy
Patient-Centered Treatment Plans for Management of Neovascular (Wet) AMD and Diabetic Macular Edema: Insights on Recent Efficacy, Safety, and Real-World Data to Improve Adherence and Outcomes
Novel Agents as Proactive Approaches to Addressing Food Allergy: The Role of the Pharmacist in Guiding Optimal Treatment